Agios Pharmaceuticals Inc (AGIO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

88 SIDNEY STREET CAMBRIDGE, MA 02139

Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across these three therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development.

Data as of 2021-07-19 09:13:17 -0400
Market Cap3.451 Billion Shares Outstanding61.574 Million Avg 30-day Volume961.449 Thousand
P/E Ratio2.17402 Dividend Yield EPS22.93
Price/Sales29.72 Debt to Equity1.08 EBITDA-354.185 Million
Price to Book Value1.5 Forward PE Enterprise Value1.116 Billion
Total Cash2.336 Billion Current Debt96.504 Million Gross Profit113.826 Million
BETA0.83135 52-week High/Low62.16 / 32.47 Next Earnings Date2021-07-29 Price to Cash FLow (P/CF) 2.0464
Data provided by IEX Cloud
View SEC Filings from AGIO instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 2 100.0% 2 (0.12%) 2 (0.12%) 0.0%
Funds Holding: 169 196 -13.78% 49 (2.88%) 59 (3.42%) -16.95%
13F shares: 63.912 Million 63.934 Million -0.03% 22.631 Million 24.769 Million -8.63%
% Ownership 91.8265 92.311 -0.52% 32.5148 35.7621 -9.08%
New Positions: 18 32 -43.75% 6 12 -50.0%
Increased Positions 58 63 -7.94% 17 16 6.25%
Closed Positions 44 43 2.33% 17 21 -19.05%
Reduced Positions 66 73 -9.59% 20 24 -16.67%
Total Calls 636.641 Thousand 538.315 Thousand 18.27% 171.052 Thousand 177.532 Thousand -3.65%
Total Puts 425.926 Thousand 720.333 Thousand -40.87% 29.796 Thousand 69.3 Thousand -57.0%
PUT/CALL Ratio 0.67 1.34 -50.0% 0.17 0.39 -56.41%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AGIO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AGIO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

91.7 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

103.5 Thousand total shares from 15 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ALENSON CARMAN PRINCIPAL ACCOUNTING OFFICER

  • Officer
3,555 2021-06-21 8

BOWDEN CHRISTOPHER CHIEF MEDICAL OFFICER

  • Officer
16,479 2021-06-18 8

MARAGANORE JOHN

  • Director
28,443 2021-05-28 2

CLANCY PAUL J

  • Director
4,964 2021-05-28 2

SCHENKEIN DAVID P

  • Director
464,131 2021-05-28 4

FOSTER-CHEEK KAYE I

  • Director
7,164 2021-05-28 2

HO MAYKIN

  • Director
4,964 2021-05-28 2

CLARK IAN T

  • Director
4,964 2021-05-28 2

SCADDEN DAVID

  • Director
5,535 2021-05-28 2

MILES DARRIN CHIEF COMMERCIAL OFFICER

  • Officer
7,209 2021-05-14 6

FOUSE JACQUALYN A CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
58,363 2021-02-14 2

BILLER JONATHAN CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-10 2

CAR BRUCE CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-02-10 2

HIRSCH ANDREW CHIEF FINANCIAL OFFICER

  • Officer
24,272 2020-04-22 0

CELGENE CORP /DE/

CELGENE EUROPEAN INVESTMENT CO LLC

CELGENE SWITZERLAND LLC

CELGENE ALPINE INVESTMENT CO., LLC

  • 10% Owner
7,121,658 2019-11-12 0

BILLER SCOTT CHIEF SCIENTIFIC OFFICER

  • Officer
86,788 2019-06-11 0

HOERTER STEVEN L. CHIEF COMMERCIAL OFFICER

  • Officer
10,941 2019-03-01 0

CANTLEY LEWIS CLAYTON JR.

  • Director
200,596 2017-12-06 0

NELSEN ROBERT

  • Director
109,230 2017-03-03 0

COLE DOUGLAS G.

  • Director
2,778 2016-08-10 0

TESSIER-LAVIGNE MARC

  • Director
0 2016-06-21 0

GODDARD GLENN SENIOR VICE PRESIDENT, FINANCE

  • Officer
0 2016-02-16 0

HIGGONS JOHN DUNCAN CHIEF OPERATING OFFICER

  • Officer
120,834 2016-01-04 0

KARSEN PERRY A

  • Director
0 2015-06-23 0

STARR KEVIN P

  • Director
  • 10% Owner
184,386 2015-02-19 0

ARCH VENTURE FUND VII LP

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

CRANDELL KEITH

BYBEE CLINTON

  • 10% Owner
No longer subject to file 2015-02-19 0

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

  • 10% Owner
No longer subject to file 2015-02-19 0

CELGENE EUROPEAN INVESTMENT CO LLC

  • 10% Owner
5,242,704 2014-12-16 0

FLAGSHIP VENTURES FUND 2007, L.P.

AFEYAN NOUBAR

KANIA EDWIN M JR

FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

  • 10% Owner
No longer subject to file 2014-06-23 0

CELGENE EUROPEAN INVESTMENT CO LLC

CELGENE CORP /DE/

CELGENE ALPINE INVESTMENT CO., LLC

  • 10% Owner
5,014,059 2014-04-29 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ALENSON CARMAN - Officer PRINCIPAL ACCOUNTING OFFICER

2021-06-23 17:28:44 -0400 2021-06-21 M 1,777 $51.51 a 1,777 direct yes 0.2297 -0.3004 0.2297 2 -5.4073 4

ALENSON CARMAN - Officer PRINCIPAL ACCOUNTING OFFICER

2021-06-23 17:28:44 -0400 2021-06-21 M 1,777 d 3,555 direct yes

ALENSON CARMAN - Officer PRINCIPAL ACCOUNTING OFFICER

2021-06-23 17:28:44 -0400 2021-06-21 S 1,777 $61.61 d 0 direct yes 0.2297 -0.3004 0.2297 2 -5.4073 4

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-22 16:44:19 -0400 2021-06-18 M 1,885 d 0 direct yes

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-22 16:44:19 -0400 2021-06-18 M 1,885 $39.76 a 17,372 direct yes 0.3191 -2.3046 0.5495 3 -5.1055 5

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-22 16:44:19 -0400 2021-06-18 S 48,493 $60.11 d 15,487 direct yes 0.3191 -2.3046 0.5495 3 -5.1055 5

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-22 16:44:19 -0400 2021-06-18 M 46,608 d 992 direct yes

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-22 16:44:19 -0400 2021-06-18 M 46,608 $50.40 a 63,980 direct yes 0.3191 -2.3046 0.5495 3 -5.1055 5

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-21 16:18:29 -0400 2021-06-17 M 2,502 $39.76 a 17,989 direct yes -0.7565 -5.8234 0.0 1 -5.8234 6

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-21 16:18:29 -0400 2021-06-17 M 2,502 d 1,885 direct yes

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-21 16:18:29 -0400 2021-06-17 S 2,502 $60.02 d 15,487 direct yes -0.7565 -5.8234 0.0 1 -5.8234 6

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-11 17:00:31 -0400 2021-06-10 S 20,853 $60.06 d 15,487 direct yes -0.103 5.2026 5.2026 6 -0.103 2

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-11 17:00:31 -0400 2021-06-10 M 20,853 d 4,387 direct yes

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-11 17:00:31 -0400 2021-06-10 M 20,853 $39.76 a 36,340 direct yes -0.103 5.2026 5.2026 6 -0.103 2

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-11 17:00:31 -0400 2021-06-09 M 7,149 $39.76 a 22,636 direct yes -0.103 5.2026 5.2026 6 -0.103 2

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-11 17:00:31 -0400 2021-06-09 M 7,149 d 25,240 direct yes

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-11 17:00:31 -0400 2021-06-09 S 7,149 $60.16 d 15,487 direct yes -0.103 5.2026 5.2026 6 -0.103 2

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-09 16:06:25 -0400 2021-06-08 S 6,675 $60.07 d 15,487 direct yes -2.958 0.4202 -15.6471 2.9748 8 -15.6471 31

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-09 16:06:25 -0400 2021-06-08 M 6,675 d 32,389 direct yes

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-09 16:06:25 -0400 2021-06-08 M 6,675 $39.76 a 22,162 direct yes -2.958 0.4202 -15.6471 2.9748 8 -15.6471 31

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-09 16:06:25 -0400 2021-06-07 M 4,268 $39.76 a 19,755 direct yes -2.958 0.4202 -15.6471 2.9748 8 -15.6471 31

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-09 16:06:25 -0400 2021-06-07 M 4,268 d 39,064 direct yes

BOWDEN CHRISTOPHER - Officer CHIEF MEDICAL OFFICER

2021-06-09 16:06:25 -0400 2021-06-07 S 4,268 $60.04 d 15,487 direct yes -2.958 0.4202 -15.6471 2.9748 8 -15.6471 31

SCADDEN DAVID - Director

2021-06-02 16:07:30 -0400 2021-05-28 M 1,686 a 5,535 direct 0.8227 4.1484 -1.9079 7.2466 13 -6.3014 19

CLANCY PAUL J - Director

2021-06-02 16:07:55 -0400 2021-05-28 M 1,686 d 0 direct

CLARK IAN T - Director

2021-06-02 16:09:26 -0400 2021-05-28 M 1,686 a 4,964 direct 0.8227 4.1484 -1.9079 7.2466 13 -6.3014 19

HO MAYKIN - Director

2021-06-02 16:06:50 -0400 2021-05-28 M 1,686 d 0 direct

SCHENKEIN DAVID P - Director

2021-06-02 16:07:14 -0400 2021-05-28 M 1,686 a 114,277 direct 0.8227 4.1484 -1.9079 7.2466 13 -6.3014 19

MARAGANORE JOHN - Director

2021-06-02 16:09:01 -0400 2021-05-28 M 1,686 d 0 direct

CLANCY PAUL J - Director

2021-06-02 16:07:55 -0400 2021-05-28 M 1,686 a 4,964 direct 0.8227 4.1484 -1.9079 7.2466 13 -6.3014 19

FOSTER-CHEEK KAYE I - Director

2021-06-02 16:08:25 -0400 2021-05-28 M 1,686 d 0 direct

HO MAYKIN - Director

2021-06-02 16:06:50 -0400 2021-05-28 M 1,686 a 4,964 direct 0.8227 4.1484 -1.9079 7.2466 13 -6.3014 19

SCADDEN DAVID - Director

2021-06-02 16:07:30 -0400 2021-05-28 M 1,686 d 0 direct

MARAGANORE JOHN - Director

2021-06-02 16:09:01 -0400 2021-05-28 M 1,686 a 28,443 direct 0.8227 4.1484 -1.9079 7.2466 13 -6.3014 19

CLARK IAN T - Director

2021-06-02 16:09:26 -0400 2021-05-28 M 1,686 d 0 direct

FOSTER-CHEEK KAYE I - Director

2021-06-02 16:08:25 -0400 2021-05-28 M 1,686 a 7,164 direct 0.8227 4.1484 -1.9079 7.2466 13 -6.3014 19

SCHENKEIN DAVID P - Director

2021-06-02 16:07:14 -0400 2021-05-28 M 1,686 d 0 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 22:15:03 UTC -0.208 0.288 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 21:45:03 UTC -0.208 0.288 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 21:15:03 UTC -0.208 0.288 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 20:45:03 UTC -0.208 0.288 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 20:15:05 UTC -0.208 0.288 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 19:45:03 UTC -0.208 0.288 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 19:15:03 UTC -0.208 0.288 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 18:45:03 UTC -0.208 0.288 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 18:15:03 UTC -0.208 0.288 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 17:45:03 UTC -0.208 0.288 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 17:15:02 UTC -0.208 0.288 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 16:45:02 UTC -0.2077 0.2877 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 16:15:03 UTC -0.2077 0.2877 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 15:45:02 UTC -0.2077 0.2877 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 15:15:03 UTC -0.2077 0.2877 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 14:45:03 UTC -0.1981 0.2781 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 14:15:03 UTC -0.1981 0.2781 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 13:45:03 UTC -0.1981 0.2781 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 13:15:03 UTC -0.1981 0.2781 850000
AGIOS PHARMACEUTICALS INC AGIO 2021-07-23 12:45:03 UTC -0.1981 0.2781 850000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund AGIO -66.0 shares, $-2310.0 2020-09-30 N-PORT
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund AGIO -598.0 shares, $-19375.2 2019-09-30 N-PORT
FundVantage Trust- Gotham Master Neutral Fund AGIO -19.0 shares, $-665.0 2020-09-30 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund AGIO -160.0 shares, $-8262.4 2021-03-31 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund AGIO -2639.0 shares, $-136277.96 2021-03-31 N-PORT
AQR Funds- AQR Multi-Asset Fund AGIO -321.0 shares, $-16576.44 2021-03-31 N-PORT
ETF Series Solutions- The Acquirers Fund AGIO -5528.0 shares, $-308462.4 2021-04-30 N-PORT
PACE SELECT ADVISORS TRUST- PACE Large Co Value Equity Investments AGIO -21460.0 shares, $-1197468.0 2021-04-30 N-PORT

Elevate your investments